162 related articles for article (PubMed ID: 15355996)
21. Overexpression of an mRNA-binding protein in human colorectal cancer.
Ross J; Lemm I; Berberet B
Oncogene; 2001 Oct; 20(45):6544-50. PubMed ID: 11641779
[TBL] [Abstract][Full Text] [Related]
22. A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development.
Nielsen J; Christiansen J; Lykke-Andersen J; Johnsen AH; Wewer UM; Nielsen FC
Mol Cell Biol; 1999 Feb; 19(2):1262-70. PubMed ID: 9891060
[TBL] [Abstract][Full Text] [Related]
23. CRD-BP shields c-myc and MDR-1 RNA from endonucleolytic attack by a mammalian endoribonuclease.
Sparanese D; Lee CH
Nucleic Acids Res; 2007; 35(4):1209-21. PubMed ID: 17264115
[TBL] [Abstract][Full Text] [Related]
24. Kinetics and regulation of site-specific endonucleolytic cleavage of human IGF-II mRNAs.
van Dijk EL; Sussenbach JS; Holthuizen PE
Nucleic Acids Res; 2001 Sep; 29(17):3477-86. PubMed ID: 11522816
[TBL] [Abstract][Full Text] [Related]
25. Regulation of c-myc mRNA decay by translational pausing in a coding region instability determinant.
Lemm I; Ross J
Mol Cell Biol; 2002 Jun; 22(12):3959-69. PubMed ID: 12024010
[TBL] [Abstract][Full Text] [Related]
26. Expression of the RNA-binding protein CRD-BP in brain and non-small cell lung tumors.
Ioannidis P; Kottaridi C; Dimitriadis E; Courtis N; Mahaira L; Talieri M; Giannopoulos A; Iliadis K; Papaioannou D; Nasioulas G; Trangas T
Cancer Lett; 2004 Jun; 209(2):245-50. PubMed ID: 15159028
[TBL] [Abstract][Full Text] [Related]
27. [Effect and possible mechanism of HnRNP E2 decoy RNA on proliferation of K562 leukemia cells].
Chen XM; Feng WL; Zhao SQ; Zeng JM; Bai WJ; Wang XZ; Huang ZG
Ai Zheng; 2006 Jul; 25(7):793-7. PubMed ID: 16831266
[TBL] [Abstract][Full Text] [Related]
28. IMP-1 displays cross-talk with K-Ras and modulates colon cancer cell survival through the novel proapoptotic protein CYFIP2.
Mongroo PS; Noubissi FK; Cuatrecasas M; Kalabis J; King CE; Johnstone CN; Bowser MJ; Castells A; Spiegelman VS; Rustgi AK
Cancer Res; 2011 Mar; 71(6):2172-82. PubMed ID: 21252116
[TBL] [Abstract][Full Text] [Related]
29. A family of IGF-II mRNA binding proteins (IMP) involved in RNA trafficking.
Nielsen FC; Nielsen J; Christiansen J
Scand J Clin Lab Invest Suppl; 2001; 234():93-9. PubMed ID: 11713986
[TBL] [Abstract][Full Text] [Related]
30. The ELAV RNA-stability factor HuR binds the 5'-untranslated region of the human IGF-IR transcript and differentially represses cap-dependent and IRES-mediated translation.
Meng Z; King PH; Nabors LB; Jackson NL; Chen CY; Emanuel PD; Blume SW
Nucleic Acids Res; 2005; 33(9):2962-79. PubMed ID: 15914670
[TBL] [Abstract][Full Text] [Related]
31. HoxA9 induces insulin-like growth factor-1 receptor expression in B-lineage acute lymphoblastic leukemia.
Whelan JT; Ludwig DL; Bertrand FE
Leukemia; 2008 Jun; 22(6):1161-9. PubMed ID: 18337761
[TBL] [Abstract][Full Text] [Related]
32. Transfection of human insulin-like growth factor-binding protein 3 gene inhibits cell growth and tumorigenicity: a cell culture model for lung cancer.
Hochscheid R; Jaques G; Wegmann B
J Endocrinol; 2000 Sep; 166(3):553-63. PubMed ID: 10974650
[TBL] [Abstract][Full Text] [Related]
33. Growth-condition-dependent regulation of insulin-like growth factor II mRNA stability.
Scheper W; Holthuizen PE; Sussenbach JS
Biochem J; 1996 Aug; 318 ( Pt 1)(Pt 1):195-201. PubMed ID: 8761471
[TBL] [Abstract][Full Text] [Related]
34. Silencing IGF-II impairs C-myc and N-ras expressions of SMMC-7721 cells via suppressing FAK/PI3K/Akt signaling pathway.
Ji Y; Wang Z; Li Z; Huang N; Chen H; Li B; Hui B
Cytokine; 2017 Feb; 90():44-53. PubMed ID: 27768959
[TBL] [Abstract][Full Text] [Related]
35. Involvement of Hu and heterogeneous nuclear ribonucleoprotein K in neuronal differentiation through p21 mRNA post-transcriptional regulation.
Yano M; Okano HJ; Okano H
J Biol Chem; 2005 Apr; 280(13):12690-9. PubMed ID: 15671036
[TBL] [Abstract][Full Text] [Related]
36. Tristetraprolin regulates Cyclin D1 and c-Myc mRNA stability in response to rapamycin in an Akt-dependent manner via p38 MAPK signaling.
Marderosian M; Sharma A; Funk AP; Vartanian R; Masri J; Jo OD; Gera JF
Oncogene; 2006 Oct; 25(47):6277-90. PubMed ID: 16702957
[TBL] [Abstract][Full Text] [Related]
37. Translational control of tumor necrosis factor-related apoptosis-inducing ligand death receptor expression in melanoma cells.
Zhang XY; Zhang XD; Borrow JM; Nguyen T; Hersey P
J Biol Chem; 2004 Mar; 279(11):10606-14. PubMed ID: 14688276
[TBL] [Abstract][Full Text] [Related]
38. Proteins binding to the leader of the 6.0 kb mRNA of human insulin-like growth factor 2 influence translation.
de Moor CH; Jansen M; Bonte EJ; Thomas AA; Sussenbach JS; Van Den Brande JL
Biochem J; 1995 Apr; 307 ( Pt 1)(Pt 1):225-31. PubMed ID: 7717979
[TBL] [Abstract][Full Text] [Related]
39. Human neuroblastoma cells use either insulin-like growth factor-I or insulin-like growth factor-II in an autocrine pathway via the IGF-I receptor: variability of IGF, IGF binding protein (IGFBP) and IGF receptor gene expression and IGF and IGFBP secretion in human neuroblastoma cells in relation to cellular proliferation.
Kiess W; Koepf G; Christiansen H; Blum WF
Regul Pept; 1997 Sep; 72(1):19-29. PubMed ID: 9404729
[TBL] [Abstract][Full Text] [Related]
40. Insulin growth factor-2 binding protein 3 (IGF2BP3) is a glioblastoma-specific marker that activates phosphatidylinositol 3-kinase/mitogen-activated protein kinase (PI3K/MAPK) pathways by modulating IGF-2.
Suvasini R; Shruti B; Thota B; Shinde SV; Friedmann-Morvinski D; Nawaz Z; Prasanna KV; Thennarasu K; Hegde AS; Arivazhagan A; Chandramouli BA; Santosh V; Somasundaram K
J Biol Chem; 2011 Jul; 286(29):25882-90. PubMed ID: 21613208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
